RGEN - REPLIGEN CORP
IEX Last Trade
145.435
-0.265 -0.182%
Share volume: 8,215
Last Updated: Fri 27 Dec 2024 08:29:55 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.90%
PREVIOUS CLOSE
CHG
CHG%
$145.70
-0.26
-0.18%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-01 | 2023-02-22 | 2023-05-02 | 2023-08-02 | 2023-10-31 | 2024-02-22 | 2024-05-01 | 2024-07-30 | |
| Assets | |||||||||
| Total Assets | 2.463 B | 2.525 B | 2.538 B | 2.549 B | 2.514 B | 2.824 B | 2.849 B | 2.862 B | |
| Current Assets | 953.233 M | 998.118 M | 1.019 B | 998.583 M | 978.456 M | 1.111 B | 1.133 B | 1.159 B | |
| Inventories | 242.695 M | 238.277 M | 244.704 M | 240.869 M | 211.372 M | 202.321 M | 198.033 M | 190.528 M | |
| Other Current Assets | 19.530 M | 120.136 M | 22.593 M | 33.754 M | 30.147 M | 33.238 M | 37.586 M | 34.983 M | |
| Short Term Investments | 19.530 M | 120.136 M | 22.593 M | 33.754 M | 30.147 M | 33.238 M | 37.586 M | 34.983 M | |
| Total Receivables | 117.645 M | 116.247 M | 133.488 M | 120.304 M | 106.158 M | 124.161 M | 115.766 M | 123.245 M | |
| Current Cash | 573.363 M | 523.458 M | 618.018 M | 603.656 M | 630.779 M | 751.323 M | 780.617 M | 809.146 M | |
| Total Non-current Assets | 1.509 B | 1.527 B | 1.519 B | 1.550 B | 1.536 B | 1.713 B | 1.716 B | 1.703 B | |
| Property Plant Equipment | 174.255 M | 190.673 M | 192.692 M | 202.564 M | 201.618 M | 207.440 M | 205.716 M | 204.599 M | |
| Other Assets | 800.000 K | 815.000 K | 1.188 M | 1.664 M | 1.444 M | 1.277 M | 956.000 K | 853.000 K | |
| Intangible Assets | 359.560 M | 353.676 M | 346.595 M | 351.704 M | 343.729 M | 400.486 M | 388.146 M | 379.813 M | |
| Goodwill | 851.406 M | 855.513 M | 856.301 M | 870.688 M | 869.252 M | 987.120 M | 985.963 M | 985.613 M | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 2.463 B | 2.525 B | 2.538 B | 2.549 B | 2.514 B | 2.824 B | 2.849 B | 2.862 B | |
| Total liabilities | 627.423 M | 613.958 M | 597.742 M | 578.077 M | 525.572 M | 853.208 M | 878.668 M | 875.562 M | |
| Total current liabilities | 410.696 M | 404.196 M | 405.321 M | 373.583 M | 363.364 M | 158.162 M | 178.315 M | 174.307 M | |
| Accounts Payable | 25.251 M | 27.554 M | 26.401 M | 23.787 M | 18.961 M | 19.563 M | 18.731 M | 20.910 M | |
| Other liabilities | 72.124 M | 55.373 M | 42.706 M | 48.159 M | 17.557 M | 17.859 M | 3.646 M | 3.707 M | |
| Current long term debt | 284.165 M | 284.615 M | 285.072 M | 285.521 M | 285.956 M | 69.452 M | 69.480 M | 69.481 M | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 510.143 M | 513.918 M | 517.725 M | |
| Other liabilities | 72.124 M | 55.373 M | 42.706 M | 48.159 M | 17.557 M | 17.859 M | 3.646 M | 3.707 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 1.835 B | 1.911 B | 1.940 B | 1.971 B | 1.989 B | 1.971 B | 1.971 B | 1.986 B | |
| Common stock | 55.498 M | 55.545 M | 55.590 M | 55.705 M | 55.766 M | 55.819 M | 55.791 M | 55.884 M | |
| Retained earnings | 348.543 M | 397.272 M | 426.101 M | 446.165 M | 464.337 M | 438.849 M | 440.943 M | 444.264 M |